INDUSTRY NEWS
China Absorbent Hygiene Products Expo,China Feminine Care Products Exрo- 2026-09
30
Tianjin Yiyi Hygiene Products Co., Ltd. Posts Operating Revenue of Approximately RMB 845 Million for H1 2026
Tianjin Yiyi Hygiene Products Co., Ltd. Posts Operating Revenue of Approximately RMB 845 Million for H1 2026 Tianjin Yiyi Hygiene Products Co., Ltd. recorded operating revenue of approximately RMB 845 million in the first half of 2026, a year-on-year decrease of 4.92%. Net profit attributable to shareholders of the listed company stood at about RMB 55.1308 million, down 46.06% year-on-year. Basic earnings per share reached RMB 0.30, a year-on-year decrease of 45.45%. - 2026-09
30
Jingxing Paper’s Tissue Paper Business Posts Revenue of Approximately RMB 372 Million in H1 2026
Jingxing Paper’s Tissue Paper Business Posts Revenue of Approximately RMB 372 Million in H1 2026 Zhejiang Jingxing Paper Joint Stock Co., Ltd. recorded total operating revenue of approximately RMB 3.161 billion in the first half of 2026, a year-on-year increase of 20.22%. Net profit attributable to shareholders of the listed company reached about RMB 139 million, rising by 152.95% year-on-year. Among them, the tissue paper business generated operating revenue of RMB 372 million, down 1.70% compared with the same period of last year, with a gross profit margin of 5.53%. - 2026-09
30
Baiya Corporation Reports Revenue of RMB 1.87 Billion for H1 2026
Baiya Corporation Reports Revenue of RMB 1.87 Billion for H1 2026 Chongqing Baiya Sanitary Products Co., Ltd. achieved operating revenue of approximately RMB 1.87 billion in the first half of 2026, a year-on-year increase of 6.04%. Net profit attributable to shareholders of the listed company stood at about RMB 179 million, down 4.82% year-on-year. Basic earnings per share were RMB 0.42, representing a year-on-year decrease of 4.55%. - 2026-09
08
Softcare Posts Approximately USD 333 Million in Operating Revenue for H1 2026, a 30.7% Year-On-Year Increase
Softcare Posts Approximately USD 333 Million in Operating Revenue for H1 2026, a 30.7% Year-On-Year Increase Softcare released its H1 2026 financial results, reporting operating revenue of approximately USD 333 million, representing a year-on-year rise of around 30.7%. Its adjusted net profit for the period stood at approximately USD 78.605 million. - 2026-09
08
C&S Achieves Dual Growth in Revenue and Profit for H1 2026
C&S Achieves Dual Growth in Revenue and Profit for H1 2026 C&S Paper Co., Ltd. reported operating revenue of approximately RMB 4.410 billion in H1 2026, representing a year-on-year increase of 1.85%. Net profit attributable to shareholders of the listed company reached around RMB 225 million, rising 50.13% compared with the same period of the prior year. Basic earnings per share stood at RMB 0.18 per share, a year-on-year jump of 50.00%. - 2026-09
08
Hengan Records an Operating Profit of Approximately RMB 1.979 Billion in H1 2026, Up 12.6% Year‑On‑Year
Hengan Records an Operating Profit of Approximately RMB 1.979 Billion in H1 2026, Up 12.6% Year‑On‑Year Hengan Group posted a turnover of approximately RMB 11.091 billion in H1 2026, a year‑on‑year decrease of 6.1%. Its operating profit stood at around RMB 1.979 billion, rising 12.6% compared with the same period of last year. Gross profit increased by 2.7% year‑on‑year to RMB 3.914 billion, with gross margin improving by 3.0 percentage points to 35.3%. Net profit attributable to shareholders of the listed company was approximately RMB 1.254 billion, down 8.7% year‑on‑year. - 2026-09
08
Lee & Man Posts HKD 14.842 Billion Revenue in H1 2026, with Tissue Paper Revenue of Approximately HKD 3.495 Billion
Lee & Man Posts HKD 14.842 Billion Revenue in H1 2026, with Tissue Paper Revenue of Approximately HKD 3.495 Billion Lee & Man China recorded a total operating revenue of approximately HKD 14.842 billion in the first half of 2026, representing a year‑on‑year increase of 21.29%. Of this total, revenue from the tissue paper business stood at about HKD 3.495 billion, rising by 25.18% year‑on‑year. Profit for the period reached HKD 1.373 billion, a year‑on‑year growth of 69.35%. In H1 2026, Lee & Man proactively seized opportunities brought by export growth and improved market demand. It continued to leverage its advantages including integrated pulp‑and‑paper layout, overseas production capacity deployment and technology upgrading to drive down costs, resulting in a remarkable improvement in overall operating performance.
电话：010-64778188 
Email：cidpex@cnppri.com
公众微信号